Atara Biotherapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Atara Biotherapeutics has a total shareholder equity of $-99.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $165.5M and $264.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$51.73m |
| Equity | -US$99.23m |
| Total liabilities | US$264.74m |
| Total assets | US$165.50m |
Recent financial health updates
Recent updates
Atara Biotherapeutics: Opportunity As They Sell Off Their Approved Asset For Longer Runway
Feb 06Here's Why Atara Biotherapeutics (NASDAQ:ATRA) Must Use Its Cash Wisely
Oct 17
Earnings Working Against Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Share Price Following 32% Dive
May 18Need To Know: Analysts Are Much More Bullish On Atara Biotherapeutics, Inc. (NASDAQ:ATRA)
Feb 13Analysts Have Just Cut Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Revenue Estimates By 16%
Nov 22EMA panel backs approval of Atara's Ebvallo for transplant complication
Oct 14Atara Bio to get additional $30M milestone payment under collaboration with Pierre Fabre
Sep 28Atara: 2 Possible Regulatory Approvals For Tab-Cel, Plus CAR T Pipeline
Aug 17Atara adds 16% ahead of Phase 2 data for multiple sclerosis candidate
Jul 12Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Intrinsic Value Is Potentially 42% Above Its Share Price
Jul 03Time To Worry? Analysts Just Downgraded Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Outlook
May 11Analysts Are Updating Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Estimates After Its Annual Results
Mar 02Atara Biotherapeutics: Early Stage Promises, Late Stage Delays
Feb 27Financial Position Analysis
Short Term Liabilities: ATRA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ATRA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ATRA is debt free.
Reducing Debt: ATRA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ATRA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ATRA has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 4.3% each year.